These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 2672806

  • 1. Use of liposomes as injectable-drug delivery systems.
    Ostro MJ, Cullis PR.
    Am J Hosp Pharm; 1989 Aug; 46(8):1576-87. PubMed ID: 2672806
    [Abstract] [Full Text] [Related]

  • 2. The liposomal formulation of doxorubicin.
    Abraham SA, Waterhouse DN, Mayer LD, Cullis PR, Madden TD, Bally MB.
    Methods Enzymol; 2005 Aug; 391():71-97. PubMed ID: 15721375
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Liposomes as drug carrier systems. Preparation, classification and therapeutic advantages of liposomes].
    Budai M, Szógyi M.
    Acta Pharm Hung; 2001 Aug; 71(1):114-8. PubMed ID: 11769091
    [Abstract] [Full Text] [Related]

  • 5. Entrapment of small molecules and nucleic acid-based drugs in liposomes.
    Fenske DB, Cullis PR.
    Methods Enzymol; 2005 Aug; 391():7-40. PubMed ID: 15721372
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Liposomes--therapeutic progress and technological problems].
    Szulc J, Dudzik M, Woyczikowski B, Sznitowska M, Janicki S.
    Pol Merkur Lekarski; 2002 Feb; 12(68):164-8. PubMed ID: 11995258
    [Abstract] [Full Text] [Related]

  • 8. Factors affecting microencapsulation of drugs in liposomes.
    Kulkarni SB, Betageri GV, Singh M.
    J Microencapsul; 1995 Feb; 12(3):229-46. PubMed ID: 7650588
    [Abstract] [Full Text] [Related]

  • 9. Recent trends in drug delivery systems: liposomal drug delivery system--preparation and characterisation.
    Chandran S, Roy A, Mishra B.
    Indian J Exp Biol; 1997 Aug; 35(8):801-9. PubMed ID: 9475051
    [Abstract] [Full Text] [Related]

  • 10. Liposomal drug delivery.
    Allison SD.
    J Infus Nurs; 2007 Aug; 30(2):89-95; quiz 120. PubMed ID: 17413493
    [Abstract] [Full Text] [Related]

  • 11. Liposomal drug delivery systems--clinical applications.
    Goyal P, Goyal K, Vijaya Kumar SG, Singh A, Katare OP, Mishra DN.
    Acta Pharm; 2005 Mar; 55(1):1-25. PubMed ID: 15907221
    [Abstract] [Full Text] [Related]

  • 12. Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice.
    Mayer LD, Tai LC, Ko DS, Masin D, Ginsberg RS, Cullis PR, Bally MB.
    Cancer Res; 1989 Nov 01; 49(21):5922-30. PubMed ID: 2790807
    [Abstract] [Full Text] [Related]

  • 13. Transfer of lipophilic drugs between liposomal membranes and biological interfaces: consequences for drug delivery.
    Fahr A, van Hoogevest P, May S, Bergstrand N, S Leigh ML.
    Eur J Pharm Sci; 2005 Nov 01; 26(3-4):251-65. PubMed ID: 16112849
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Lymphoid tissue targeting of anti-HIV drugs using liposomes.
    Désormeaux A, Bergeron MG.
    Methods Enzymol; 2005 Nov 01; 391():330-51. PubMed ID: 15721390
    [Abstract] [Full Text] [Related]

  • 16. Advances in lipid nanodispersions for parenteral drug delivery and targeting.
    Constantinides PP, Chaubal MV, Shorr R.
    Adv Drug Deliv Rev; 2008 Mar 17; 60(6):757-67. PubMed ID: 18096269
    [Abstract] [Full Text] [Related]

  • 17. The role of tumor-associated macrophages in the delivery of liposomal doxorubicin to solid murine fibrosarcoma tumors.
    Mayer LD, Dougherty G, Harasym TO, Bally MB.
    J Pharmacol Exp Ther; 1997 Mar 17; 280(3):1406-14. PubMed ID: 9067330
    [Abstract] [Full Text] [Related]

  • 18. Liposomal nanomedicines.
    Fenske DB, Cullis PR.
    Expert Opin Drug Deliv; 2008 Jan 17; 5(1):25-44. PubMed ID: 18095927
    [Abstract] [Full Text] [Related]

  • 19. Liposomal cyclosporine. Comparison of drug and lipid carrier pharmacokinetics and biodistribution.
    Choice E, Masin D, Bally MB, Meloche M, Madden TD.
    Transplantation; 1995 Nov 15; 60(9):1006-11. PubMed ID: 7491673
    [Abstract] [Full Text] [Related]

  • 20. Direct comparison of two pegylated liposomal doxorubicin formulations: is AUC predictive for toxicity and efficacy?
    Cui J, Li C, Guo W, Li Y, Wang C, Zhang L, Zhang L, Hao Y, Wang Y.
    J Control Release; 2007 Apr 02; 118(2):204-15. PubMed ID: 17239468
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.